611 W. Union Street
Benson, AZ 85602
(520) 586-0800

member support line
M-F 5pm-8pm
24/7 weekends/holidays

AzCH Nurse Assist Line


611 W. Union Street
Benson, AZ 85602
(520) 586-0800

AzCH Nurse Assist Line


powered by centersite dot net
Health Sciences
Basic InformationLatest News
Certain Blood Thinners Can Raise Risk of 'Delayed' Bleeding After Head InjuryAHA News: Former NFL Players With Lots of Concussions May Have Higher Stroke RiskMore Years Playing Football, More Brain Lesions on MRI: StudyNew Insights Into What Might Drive Parkinson's DiseaseBrain's 'White Matter' Changes in People With AutismWearable Vibration Device May Ease Parkinson's TremorNeurologists' Group Issues New Treatment Guidelines for Early Parkinson'sGene Therapy Could Be Big Advance Against HemophiliaBlood Test Looks at Patients' Whole Genome to Spot Rare Inherited DiseasesSales of Unproven, Unapproved Stem Cell Therapies Are BoomingHow Bilingual Brains Shift Quickly Between LanguagesMouse Study Offers Hope for Gene Therapy Against Parkinson's DiseaseInsomnia Tied to Raised Risk of AneurysmAHA News: Could the Path to Better Brain Health Involve Better Mouth Care?More Americans Are Dying From Parkinson's Disease: StudyTen Years On, Gene Therapy Still Beating Most Cases of 'Bubble Boy' Immune DiseaseResearchers Find Better Way to Fight Breast Cancer That Has Spread to BrainShape, Size of Brain Arteries May Predict Stroke RiskTracking Key Protein Helps Predict Outcomes in TBI PatientsSigns of Early Alzheimer's May Be Spotted in Brain StemCould Cholesterol Help Drive Alzheimer's Disease?Insights Into Genes Driving Epilepsy Could Help With TreatmentFewer American Adults Are Getting Malignant Brain TumorsLong-Term Outlook for Most With Serious Brain Injury Is Better Than ThoughtStroke Prevented His Speech, But Brain Implant Brought It BackWHO Calls for Global Registry of Human Genome EditingScientists Track Spirituality in the Human BrainNew Insights Into How Eating Disorders Alter the BrainGene Differences Could Have Black Patients Undergoing Unnecessary BiopsiesCRISPR Therapy Fights Rare Disease Where Protein Clogs OrgansNew Genetic Insights Into Cause of ALSDeep Brain Stimulation Therapy May Help Parkinson's Patients Long TermAmazon Tribe Could Hold Key to Health of Aging BrainsMan Blind for 40 Years Regains Some Sight Through Gene TherapyNew Insights Into Treating Mild Head Injuries'Ghosts and Guardian Angels': New Insights Into Parkinson's HallucinationsHigher Education Won't Help Preserve the Aging Brain: StudyScientists Create Embryos With Cells From Monkeys, Humans'Game of Thrones' Study Reveals the Power of Fiction on the MindScientists Create Human Tear Glands That Cry in the LabAHA News: How Grief Rewires the Brain and Can Affect Health – and What to Do About ItCould Taking a Swing at Golf Help Parkinson's Patients?Autopsy Study May Explain Why Some COVID Survivors Have 'Brain Fog'Gene Study Probes Origins of Addison's DiseaseCould a Common Prostate Drug Help Prevent Parkinson's?AHA News: Hormones Are Key in Brain Health Differences Between Men and WomenNerve Drug Might Curb Spinal Cord Damage, Mouse Study SuggestsIs There a 'Risk-Taking' Center in the Brain?AHA News: Dr. Dre Recovering From a Brain Aneurysm. What Is That?Can 2 Nutrients Lower Your Risk for Parkinson's?
Questions and AnswersLinksBook Reviews
Related Topics

Medical Disorders
Mental Disorders
Mental Health Professions

Sales of Unproven, Unapproved Stem Cell Therapies Are Booming

HealthDay News
by Robert Preidt
Updated: Nov 8th 2021

new article illustration

MONDAY, Nov. 8, 2021 (HealthDay News) -- The sale of unproven and unapproved stem cell treatments has skyrocketed in the United States, according to a new five-year study.

The study found a fourfold jump since 2016 in the availability of the treatments, which claim to do everything from relieving pain to slowing aging.

People who use these treatments are needlessly spending thousands of dollars and could be putting their health at risk, study author Leigh Turner warned.

"One of the most troubling features of this marketplace is that businesses selling unproven and non-FDA-approved stem cell products often use marketing misrepresentations and aggressive sales tactics to exploit the hope, suffering, fear or desperation of patients," said Turner, a professor of health, society and behavior at the University of California (UC), Irvine.

Using online search tools, the study identified 1,480 U.S. businesses and 2,754 clinics offering purported stem cell treatments. That compares to 351 businesses and 570 clinics that did so five years ago.

The United States now has more locations offering such treatments than any other country, including those that were once hot spots for so-called "stem cell tourism," the findings showed.

Stem cell therapy, also known as regenerative medicine, has resulted in life-saving treatment of patients with certain types of cancer and blood diseases. But the safety and effectiveness of stem cell products needs further testing, according to a university news release.

In this study, the states with the highest number of stem cell clinics are California (347), Texas (333) and Florida (310).

The findings were published online Nov. 4 in the journal Cell Stem Cell.

"Many of these 'clinics' are promoting unlicensed and unproven stem cell products and claim their interventions do not require FDA approval," said Turner, a member of UC-Irvine's stem cell research center and ethics leader at its Institute for Clinical and Translational Science. "However, that couldn't be further from the truth."

Turner said there is widespread promotion of products that do require authorization by the U.S. Food and Drug Administration before marketing.

"In many cases, these clinics are using misleading advertising and predatory marketing techniques," he warned.

Claims about the treatments include helping with pain (85%+), orthopedic diseases and injuries (46%+), and sports-related injuries (22%+). The claims range from helping with hair loss and slowing the aging process to strengthening the immune system to protect against SARS-CoV-2, the virus that causes COVID-19.

Out-of-pocket costs for the treatments range from $1,200 to $28,000, with an average of about $5,100.

Unproven and unapproved stem cell products pose numerous risks to patients and have caused some serious harm to some, according to Turner, who added that the situation is likely to continue unless the FDA and other agencies step up enforcement.

More information

Read a U.S. Food and Drug Administration warning about unapproved stem cell therapies.

SOURCE: University of California, Irvine, news release, Nov. 4, 2021